Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 8(1): 4350, 2018 03 12.
Artigo em Inglês | MEDLINE | ID: mdl-29531232

RESUMO

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disorder that may lead to sudden death and can affect humans and other primates. In 2012, the alpha male bonobo of the Milwaukee County Zoo died suddenly and histologic evaluation found features of ARVC. This study sought to discover a possible genetic cause for ARVC in this individual. We sequenced our subject's DNA to search for deleterious variants in genes involved in cardiovascular disorders. Variants found were annotated according to the human genome, following currently available classification used for human diseases. Sequencing from the DNA of an unrelated unaffected bonobo was also used for prediction of pathogenicity. Twenty-four variants of uncertain clinical significance (VUSs) but no pathogenic variants were found in the proband studied. Further familial, functional, and bonobo population studies are needed to determine if any of the VUSs or a combination of the VUSs found may be associated with the clinical findings. Future genotype-phenotype establishment will be beneficial for the appropriate care of the captive zoo bonobo population world-wide as well as conservation of the bobono species in its native habitat.


Assuntos
Doenças dos Símios Antropoides/genética , Displasia Arritmogênica Ventricular Direita/genética , Displasia Arritmogênica Ventricular Direita/veterinária , Testes Genéticos/métodos , Pan paniscus/genética , Animais , Bases de Dados Genéticas , Morte Súbita Cardíaca/veterinária , Feminino , Genoma Humano , Variação Estrutural do Genoma , Humanos , Masculino , Miocárdio/patologia
2.
J Virol ; 89(24): 12480-91, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26446599

RESUMO

UNLABELLED: Simian foamy virus (SFV) is a ubiquitous retrovirus in nonhuman primates (NHPs) that can be transmitted to humans, mostly through severe bites. In the past few years, our laboratory has identified more than 50 hunters from central Africa infected with zoonotic SFVs. Analysis of the complete sequences of five SFVs obtained from these individuals revealed that env was the most variable gene. Furthermore, recombinant SFV strains, some of which involve sequences in the env gene, were recently identified. Here, we investigated the variability of the env genes of zoonotic SFV strains and searched for possible recombinants. We sequenced the complete env gene or its surface glycoprotein region (SU) from DNA amplified from the blood of (i) a series of 40 individuals from Cameroon or Gabon infected with a gorilla or chimpanzee foamy virus (FV) strain and (ii) 1 gorilla and 3 infected chimpanzees living in the same areas as these hunters. Phylogenetic analyses revealed the existence of two env variants among both the gorilla and chimpanzee FV strains that were present in zoonotic and NHP strains. These variants differ greatly (>30% variability) in a 753-bp-long region located in the receptor-binding domain of SU, whereas the rest of the gene is very conserved. Although the organizations of the Env protein sequences are similar, the potential glycosylation patterns differ between variants. Analysis of recombination suggests that the variants emerged through recombination between different strains, although all parental strains could not be identified. IMPORTANCE: SFV infection in humans is a great example of a zoonotic retroviral infection that has not spread among human populations, in contrast to human immunodeficiency viruses (HIVs) and human T-lymphotropic viruses (HTLVs). Recombination was a major mechanism leading to the emergence of HIV. Here, we show that two SFV molecular envelope gene variants circulate among ape populations in Central Africa and that both can be transmitted to humans. These variants differ greatly in the SU region that corresponds to the part of the Env protein in contact with the environment. These variants may have emerged through recombination between SFV strains infecting different NHP species.


Assuntos
Produtos do Gene env/genética , Filogenia , Recombinação Genética , Infecções por Retroviridae/genética , Vírus Espumoso dos Símios/genética , Animais , Doenças dos Símios Antropoides/epidemiologia , Doenças dos Símios Antropoides/genética , Doenças dos Símios Antropoides/virologia , Camarões , Gabão , Gorilla gorilla , Humanos , Pan troglodytes , Infecções por Retroviridae/epidemiologia , Infecções por Retroviridae/veterinária
3.
PLoS One ; 7(5): e36570, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22590569

RESUMO

While much attention has been focused on the molecular epidemiology of retroviruses in wild primate populations, the correlated question of the frequency and nature of super-infection events, i.e., the simultaneous infection of the same individual host with several strains of the same virus, has remained largely neglected. In particular, methods possibly allowing the investigation of super-infection from samples collected non-invasively (such as faeces) have never been properly compared. Here, we fill in this gap by assessing the costs and benefits of end-point dilution PCR (EPD-PCR) and multiple bulk-PCR cloning, as applied to a case study focusing on simian foamy virus super-infection in wild chimpanzees (Pan troglodytes). We show that, although considered to be the gold standard, EPD-PCR can lead to massive consumption of biological material when only low copy numbers of the target are expected. This constitutes a serious drawback in a field in which rarity of biological material is a fundamental constraint. In addition, we demonstrate that EPD-PCR results (single/multiple infection; founder strains) can be well predicted from multiple bulk-PCR clone experiments, by applying simple statistical and network analyses to sequence alignments. We therefore recommend the implementation of the latter method when the focus is put on retroviral super-infection and only low retroviral loads are encountered.


Assuntos
Doenças dos Símios Antropoides/genética , Pan troglodytes/virologia , Infecções por Retroviridae/genética , Vírus Espumoso dos Símios/genética , Animais , Doenças dos Símios Antropoides/virologia , Reação em Cadeia da Polimerase/métodos , Infecções por Retroviridae/veterinária , Alinhamento de Sequência , Carga Viral/genética
4.
J Virol ; 80(14): 7208-18, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16809326

RESUMO

Current data suggest that the human immunodeficiency virus type 1 (HIV-1) epidemic arose by transmission of simian immunodeficiency virus (SIV) SIVcpz from a subspecies of common chimpanzees (Pan troglodytes troglodytes) to humans. SIVcpz of chimpanzees is itself a molecular chimera of SIVs from two or more different monkey species, suggesting that recombination was made possible by coinfection of one individual animal with different lentiviruses. However, very little is known about SIVcpz transmission and the susceptibility to lentivirus coinfection of its natural host, the chimpanzee. Here, it is revealed that either infected plasma or peripheral blood mononuclear cells readily confer infection when exposure occurs by the intravenous or mucosal route. Importantly, the presence of preexisting HIV-1 infection did not modify the kinetics of SIVcpz infection once it was established by different routes. Although humoral responses appeared as early as 4 weeks postinfection, neutralization to SIVcpz-ANT varied markedly between animals. Analysis of the SIVcpz env sequence over time revealed the emergence of genetic viral variants and persistent SIVcpz RNA levels of between 10(4) and 10(5) copies/ml plasma regardless of the presence or absence of concurrent HIV-1 infection. These unique data provide important insight into possible routes of transmission, the kinetics of acute SIVcpz infection, and how readily coinfection with SIVcpz and other lentiviruses may be established as necessary preconditions for potential recombination.


Assuntos
Doenças dos Símios Antropoides/sangue , Infecções por HIV/transmissão , HIV-1 , Pan troglodytes/sangue , Síndrome de Imunodeficiência Adquirida dos Símios/transmissão , Vírus da Imunodeficiência Símia , Animais , Doenças dos Símios Antropoides/genética , Doenças dos Símios Antropoides/virologia , Quimera , Evolução Molecular , Produtos do Gene env/genética , Anticorpos Anti-HIV/sangue , Infecções por HIV/sangue , Infecções por HIV/complicações , Infecções por HIV/genética , HIV-1/genética , Pan troglodytes/virologia , RNA Viral/sangue , RNA Viral/genética , Recombinação Genética , Síndrome de Imunodeficiência Adquirida dos Símios/sangue , Síndrome de Imunodeficiência Adquirida dos Símios/complicações , Síndrome de Imunodeficiência Adquirida dos Símios/genética , Especificidade da Espécie
5.
J Zoo Wildl Med ; 35(4): 520-4, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15732594

RESUMO

Two juvenile, male, captive-born lowland gorillas (Gorilla gorilla gorilla) with the same father but different mothers developed bilateral cataracts. The cataracts were surgically removed within 6 yr and 3 mo, respectively, of diagnosis, and foldable intraocular lenses were implanted. Although vision was not restored in one eye with a mature, 6-yr-old cataract in gorilla A, surgical intervention on the other eye was performed before a complete cataract developed, and vision was fully restored. Gorilla B was treated at the age of 17 mo, and normal visual development proceeded in both eyes. This animal developed bilateral after-cataract and therefore needed a second intervention in both eyes using Nd:YAG laser treatment. The genetic component of juvenile cataracts should be considered in breeding management programs.


Assuntos
Doenças dos Símios Antropoides/cirurgia , Extração de Catarata/veterinária , Catarata/veterinária , Gorilla gorilla/cirurgia , Implante de Lente Intraocular/veterinária , Animais , Animais de Zoológico , Doenças dos Símios Antropoides/genética , Catarata/genética , Extração de Catarata/métodos , Gorilla gorilla/genética , Masculino , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA